CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
12.08
+0.58 (5.04%)
At close: Aug 13, 2025, 4:00 PM
11.90
-0.18 (-1.49%)
Pre-market: Aug 14, 2025, 9:14 AM EDT
CorMedix Employees
As of December 31, 2024, CorMedix had 65 total employees, including 64 full-time and 1 part-time employees. The number of employees decreased by 18 or -21.69% compared to the previous year.
Employees
65
Change (1Y)
-18
Growth (1Y)
-21.69%
Revenue / Employee
$1,868,992
Profits / Employee
$787,069
Market Cap
901.76M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CRMD News
- 5 days ago - CorMedix, Inc. (CRMD) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - CorMedix to Buy Melinta Therapeutics for $300 Million - WSJ
- 7 days ago - Melinta Therapeutics Announces Strategic Acquisition by CorMedix, Underscoring Its Portfolio Value and Industry Leadership - Business Wire
- 7 days ago - CorMedix to acquire Melinta Therapeutics, Creating Diversified Specialty Company With Strong Presence in Acute Care Settings - GlobeNewsWire
- 7 days ago - Cormedix Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 6 weeks ago - CorMedix Analyst Says Investors Could Be Further Rewarded - Benzinga
- 6 weeks ago - CorMedix Seems Significantly Undervalued - Seeking Alpha
- 6 weeks ago - Concentrix Posts Downbeat Earnings, Joins CorMedix And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga